The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

Cytotherapy ◽  
2013 ◽  
Vol 15 (1) ◽  
pp. 2-8 ◽  
Author(s):  
Jacques Galipeau
Cytotherapy ◽  
2017 ◽  
Vol 19 (5) ◽  
pp. S224
Author(s):  
J Keto ◽  
T Kaartinen ◽  
U Salmenniemi ◽  
J Partanen ◽  
A Hänninen ◽  
...  

2013 ◽  
Vol 55 (5) ◽  
pp. 1203-1205 ◽  
Author(s):  
Lucia Silla ◽  
Vanessa Valim ◽  
Bruna Amorin ◽  
Ana Paula Alegretti ◽  
Fernanda dos Santos de Oliveira ◽  
...  

2019 ◽  
Vol 185 (1) ◽  
pp. 89-92 ◽  
Author(s):  
Antonio Galleu ◽  
Dragana Milojkovic ◽  
Simona Deplano ◽  
Richard Szydlo ◽  
Sandra Loaiza ◽  
...  

PLoS ONE ◽  
2019 ◽  
Vol 14 (6) ◽  
pp. e0217572 ◽  
Author(s):  
Liad Hinden ◽  
Mordechai Avner ◽  
Polina Stepensky ◽  
Reuven Or ◽  
Osnat Almogi-Hazan

Sign in / Sign up

Export Citation Format

Share Document